UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033269
Receipt number R000037931
Scientific Title Exploratory research of liquid biopsy for patients with cancer
Date of disclosure of the study information 2018/07/04
Last modified on 2019/01/04 18:35:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory research of liquid biopsy for patients with cancer

Acronym

Liquid biopsy for cancer

Scientific Title

Exploratory research of liquid biopsy for patients with cancer

Scientific Title:Acronym

Liquid biopsy for cancer

Region

Japan


Condition

Condition

cancer

Classification by specialty

Not applicable

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To examine the feasibility and utility of liquid biopsy (ctDNA detection) for detection of cancer in early stage, monitoring of tumor recurrence, tumor response to anti-cancer therapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

detection of somatic mutation in cfDNA

Key secondary outcomes

time-course change in ctDNA


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

200 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who satisfy the below
1)Pathologically diagnosed as caner
2)20 or more years old
3)patients who understand and agree with the enrollment of this study with IC form.

Key exclusion criteria

Patients who do not satisfy the inclusion criteria

Target sample size

800


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hitoshi Zembutsu

Organization

Cancer Institute

Division name

Cancer Precision Medicine Center

Zip code


Address

3-8-1, Ariake, koto-ku, Tokyo

TEL

03-3570-0509

Email

hitoshi.zembutsu@jfcr.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hitoshi Zembutsu

Organization

Cancer Institute

Division name

Cancer Precision Medicine Center

Zip code


Address

3-8-1, Ariake, koto-ku, Tokyo

TEL

03-3570-0509

Homepage URL


Email

hitoshi.zembutsu@jfcr.or.jp


Sponsor or person

Institute

Cancer Precision Medicine Center
Cancer Institute,

Institute

Department

Personal name



Funding Source

Organization

KAKENHI, JSPS

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

がん研究会


Other administrative information

Date of disclosure of the study information

2018 Year 07 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 06 Month 20 Day

Date of IRB


Anticipated trial start date

2017 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The result of this study will be reported in meeting or papers.


Management information

Registered date

2018 Year 07 Month 04 Day

Last modified on

2019 Year 01 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037931


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name